Journal article · 2025 · Open access

CONSORT 2025 statement: updated guideline for reporting randomised trials

Sally Hopewell, An‐Wen Chan, Professor Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz, Ruth Tunn, Rakesh Aggarwal, Michael Berkwits, Jesse A. Berlin, Nita Bhandari, Nancy J. Butcher and 27 more

BMJ, 389, e081123 · Published 14 April 2025 · DOI 10.1136/bmj-2024-081123

Free PDFView at the publisherCite this paper

In brief

“CONSORT 2025 statement: updated guideline for reporting randomised trials” is a 2025 journal article by Sally Hopewell and 38 co-authors, published in BMJ. OpenAlex counts 1,822 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at BMJ.

Citations
1,822
Most cited in
2026 (1,371)
Field-weighted impact
375.74
References
51
Authors
39

Abstract

BACKGROUND: Well designed and properly executed randomised trials are considered the most reliable evidence on the benefits of healthcare interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Trials) statement was designed to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomised trial. CONSORT was first published in 1996, then updated in 2001 and 2010. Here, we present the updated CONSORT 2025 statement, which aims to account for recent methodological advancements and feedback from end users. METHODS: We conducted a scoping review of the literature and developed a project-specific database of empirical and theoretical evidence related to CONSORT, to generate a list of potential changes to the checklist. The list was enriched with recommendations provided by the lead authors of existing CONSORT extensions (Harms, Outcomes, Non-pharmacological Treatment), other related reporting guidelines (TIDieR) and recommendations from other sources (eg, personal communications). The list of potential changes to the checklist was assessed in a large, international, online, three-round Delphi survey involving 317 participants and discussed at a two-day online expert consensus meeting of 30 invited international experts. RESULTS: We have made substantive changes to the CONSORT checklist. We added seven new checklist items, revised three items, deleted one item, and integrated several items from key CONSORT extensions. We also restructured the CONSORT checklist, with a new section on open science. The CONSORT 2025 statement consists of a 30-item checklist of essential items that should be included when reporting the results of a randomised trial and a diagram for documenting the flow of participants through the trial. To facilitate implementation of CONSORT 2025, we have also developed an expanded version of the CONSORT 2025 checklist, with bullet points eliciting critical elements of each item. CONCLUSION: Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomised trials to ensure that trial reports are clear and transparent.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hopewell, S., Chan, A., Collins, P. G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., Bhandari, N., Butcher, N. J., Campbell, M., Chidebe, R. C., Elbourne, D. R., Farmer, A. A., Fergusson, D. A., Golub, R. M., Goodman, S. N., . . . Boutron, I. (2025). CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ, 389, e081123. https://doi.org/10.1136/bmj-2024-081123

MLA 9

Hopewell, Sally, et al. “CONSORT 2025 statement: updated guideline for reporting randomised trials.” BMJ, vol. 389, 2025, p. e081123. https://doi.org/10.1136/bmj-2024-081123.

Chicago

Hopewell, Sally, An‐Wen Chan, Professor Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz, Ruth Tunn, et al. 2025. “CONSORT 2025 statement: updated guideline for reporting randomised trials.” BMJ 389: e081123. https://doi.org/10.1136/bmj-2024-081123.

Harvard

Hopewell, S. et al. (2025) ‘CONSORT 2025 statement: updated guideline for reporting randomised trials’, BMJ, 389, p. e081123. doi:10.1136/bmj-2024-081123.

IEEE

S. Hopewell et al., “CONSORT 2025 statement: updated guideline for reporting randomised trials,” BMJ, vol. 389, p. e081123, 2025, doi: 10.1136/bmj-2024-081123.

BibTeX

@article{hopewell2025consort,
  title     = {{CONSORT 2025 statement: updated guideline for reporting randomised trials}},
  author    = {Hopewell, Sally and Chan, An‐Wen and Collins, Professor Gary S. and Hróbjartsson, Asbjørn and Moher, David and Schulz, Kenneth F. and Tunn, Ruth and Aggarwal, Rakesh and Berkwits, Michael and Berlin, Jesse A. and Bhandari, Nita and Butcher, Nancy J. and Campbell, Marion and Chidebe, Runcie C.W. and Elbourne, Diana R. and Farmer, Andrew A. and Fergusson, Dean A. and Golub, Robert M. and Goodman, Steven N. and Hoffmann, Tammy and Ioannidis, John P. A. and Kahan, Brennan C and Knowles, Rachel Louise and Lamb, Sarah E and Lewis, Steff C. and Loder, Elizabeth and Offringa, Martin and Ravaud, Philippe and Richards, Dawn P. and Rockhold, Frank W. and others},
  journal   = {BMJ},
  year      = {2025},
  volume    = {389},
  pages     = {e081123},
  doi       = {10.1136/bmj-2024-081123},
  url       = {https://doi.org/10.1136/bmj-2024-081123}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201711
202411
2025449449
20261,3711371

Its field-weighted citation impact is 375.74: it has been cited 375.74 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews

  • reporting guidelines
  • randomised trials
  • trial reporting quality
  • CONSORT checklist
  • CONSORT extension
  • harms reporting
  • non-pharmacological treatment
  • open science

Work with this paper

Most-cited papers in Decision Sciences

All highly cited Decision Sciences papers

Questions about this paper

How do I cite this paper in APA style?

Hopewell, S., Chan, A., Collins, P. G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., Bhandari, N., Butcher, N. J., Campbell, M., Chidebe, R. C., Elbourne, D. R., Farmer, A. A., Fergusson, D. A., Golub, R. M., Goodman, S. N., . . . Boutron, I. (2025). CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ, 389, e081123. https://doi.org/10.1136/bmj-2024-081123

How many times has this paper been cited?

1,822 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at BMJ.

Who wrote this paper?

Sally Hopewell, An‐Wen Chan, Professor Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz, Ruth Tunn, Rakesh Aggarwal, Michael Berkwits, Jesse A. Berlin, Nita Bhandari, Nancy J. Butcher and 27 more.

What is the DOI of this paper?

10.1136/bmj-2024-081123. The permanent link is https://doi.org/10.1136/bmj-2024-081123.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.